EUCTR2004-005002-68-IT进行中（未招募）1 期
A multicentre, randomised, double-blind, parallel group, phase IV study to compare the renal effects of the non-ionic iso-osmolar contrast medium iodixanol 320 mgI/mL Visipaque with the non-ionic low osmolar contrast medium iopamidol 370 mgI/mL in subjects with impaired renal function and diabetes mellitus undergoing coronary angiography with or without percutaneous coronary intervention PCI .
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 450
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Efficacy and safety study of benralizumab in asthmatic adults and adolescents inadequately controlled on inhaled corticosteroid plus LABAMedDRA version: 19.0Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersAsthmaEUCTR2013-002163-26-PLAstraZeneca AB1,296
进行中（未招募）
1 期
Efficacy and safety study of benralizumab added to high-dose inhaled corticosteroid plus LABA in patients with uncontrolled asthmaAsthmaMedDRA version: 18.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2013-002345-11-CZAstraZeneca AB1,134
进行中（未招募）
1 期
Efficacy and safety study of benralizumab added to high-dose inhaled corticosteroid plus LABA in patients with uncontrolled asthmaAsthmaEUCTR2013-002345-11-ESAstraZeneca AB1,134
进行中（未招募）
1 期
A clinical study on the therapeutic efficacy and safety of Febuxostat and Allopurinol on serum urate concentration in subjects suffering from hyperuricemia and gouthyperuricemia and goutMedDRA version: 15.1 Level: PT Classification code 10018627 Term: Gout System Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 15.1 Level: LLT Classification code 10020907 Term: Hyperuricemia System Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2012-001858-25-ESMENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A.330
进行中（未招募）
不适用
Efficacy and safety study of benralizumab in asthmatic adults and adolescents inadequately controlled on inhaled corticosteroid plus LABAMedDRA version: 17.0Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersAsthmaEUCTR2013-002163-26-SEAstraZeneca AB1,296